The current NUVL market cap is 4.04B. The company's latest EPS is USD -1.9701 and P/E is -32.01.
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -20.39M | -29.3M | -30.21M | -34.06M | -38.78M |
Net Income | -19.72M | -26.12M | -25.19M | -29.09M | -33.65M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -10.36M | -16.91M | -45.82M | -86.11M | -149.49M |
Net Income | -11.81M | -14.56M | -46.34M | -81.85M | -126.22M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 249.56M | 482.46M | 460.99M | 441.95M | 425.08M |
Total Liabilities | 12.98M | 19.48M | 17.02M | 20.8M | 29.1M |
Total Equity | 236.58M | 462.98M | 443.97M | 421.15M | 395.98M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 3.32M | 10.65M | 293.82M | 482.46M | 732.38M |
Total Liabilities | 6.52M | 6.62M | 8.79M | 19.48M | 31.82M |
Total Equity | -17.26M | -31.32M | 285.04M | 462.98M | 700.56M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -47.19M | -64.97M | -24.41M | -46.55M | -69.53M |
Investing | 54.74M | -10.67M | -127.26M | -125.67M | -87.27M |
Financing | 243k | 248.92M | -17k | 1.28M | 3.42M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -9.64M | -14.95M | -40M | -64.97M | -99.74M |
Investing | N/A | N/A | -220.03M | -10.67M | -143.53M |
Financing | N/A | 22.27M | 318.22M | 248.92M | 336.85M |
Market Cap | 4.04B |
Price to Earnings Ratio | -32.01 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 12.05 |
Price to Book Ratio | 5.77 |
Dividend Yield | - |
Shares Outstanding | 64.07M |
Average Volume (1 week) | 576.16k |
Average Volume (1 Month) | 569.58k |
52 Week Change | 105.74% |
52 Week High | 89.39 |
52 Week Low | 29.25 |
Spread (Intraday) | 10.23 (15.45%) |
Company Name | Nuvalent Inc |
Address |
corporation trust center wilmington, delaware 19801 |
Website | https://www.nuvalent.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.